Retroperitoneal germ cell tumor diagnosed by endoscopic ultrasound-guided fine needle aspiration

le Womeldorph, Craig M, Zalupski, Mark M, Knoepp, Stewart M, Soltani, Mohammad, Elmunzer, B Joseph
Foilsithe 2010

Using (18)F Fluorodeoxyglucose Positron Emission Tomography (FDG PET) to Monitor Clinical Outcomes in Patients Treated with Neoadjuvant Chemo-Radiotherapy for Locally Advanced Panc...

le Choi, Minsig, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Lawhorn-Crews, Jawana M., Zalupski, Mark M., Shields, Anthony F.
Foilsithe 2010

A phase II study of biweekly cisplatin, fixed dose rate gemcitabine and infusional 5-fluorouracil in patients with metastatic pancreatic and biliary cancers

le Davis, Elizabeth J., Griffith, Kent A., Kim, Edward J., Ruch, Joshua M., McDonnell, Kevin J., Zalupski, Mark M.
Foilsithe in Am J Clin Oncol (2018)

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

le HAMMAD, Nazik, HEILBRUN, Lance K, PHILIP, Philip A, SHIELDS, Anthony F, ZALUPSKI, Mark M, VENKATRAMANAMOORTHY, Raghu, EL-RAYES, Bassel F
Foilsithe 2010

A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer

le Gartner, Elaina M., Griffith, Kent A., Pan, Quintin, Brewer, George J., Henja, Gwen F., Merajver, Sofia D., Zalupski, Mark M.
Foilsithe 2008

DEPTOR has growth suppression activity against pancreatic cancer cells

le Li, Hua, Sun, Grace Y., Zhao, Yongchao, Thomas, Dafydd, Greenson, Joel K., Zalupski, Mark M., Ben-Josef, Edgar, Sun, Yi
Foilsithe in Oncotarget (2014)

Neoadjuvant Stereotactic Body Radiation Therapy (SBRT), Capecitabine, and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma

le Welling, Theodore H., Feng, Mary, Wan, Shanshan, Hwang, Sin Ye, Volk, Michael L., Lawrence, Theodore S., Zalupski, Mark M., Sonnenday, Christopher J.
Foilsithe 2013

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

le Davis, Elizabeth J., Zhao, Lili, Lucas, David R., Schuetze, Scott M., Baker, Laurence H., Zalupski, Mark M., Thomas, Dafydd, Chugh, Rashmi
Foilsithe in BMC Cancer (2016)

Prognostic Significance of Carbohydrate Antigen 19-9 in Unresectable Locally Advanced Pancreatic Cancer Treated With Dose-Escalated Intensity Modulated Radiation Therapy and Concur...

le Vainshtein, Jeffrey M., Schipper, Matthew, Zalupski, Mark M., Lawrence, Theodore S., Abrams, Ross, Francis, Isaac R., Khan, Gazala, Leslie, William, Ben-Josef, Edgar
Foilsithe 2012

Carbohydrate Antigen 19-9 Is a Prognostic and Predictive Biomarker in Patients With Advanced Pancreatic Cancer Who Receive Gemcitabine-Containing Chemotherapy: A Pooled Analysis of...

le Bauer, Todd M., El-Rayes, Bassel F., Li, Xiaobai, Hammad, Nazik, Philip, Philip A., Shields, Anthony F., Zalupski, Mark M., Bekaii-Saab, Tanios
Foilsithe in Cancer (2012)

Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy

le Cuneo, Kyle C., Morgan, Meredith A., Griffith, Kent A., Hawkins, Peter G., Greenson, Joel K., Ben-Josef, Edgar, Lawrence, Theodore S., Zalupski, Mark M.
Foilsithe in Int J Radiat Oncol Biol Phys (2017)

Original Article A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

le Cohen, Steven J., Zalupski, Mark M., Modiano, Manuel R., Conkling, Paul, Patt, Yehuda Z., Davis, Peg, Dorr, Robert T., Boytim, Michelle L., Hersh, Evan M.
Foilsithe 2009

A Phase I Trial of Cabozantinib and Gemcitabine in Advanced Pancreatic Cancer

le Zhen, David B, Griffith, Kent A, Ruch, Joshua M, Camphausen, Kevin, Savage, Jason E, Kim, Edward J, Sahai, Vaibhav, Simeone, Diane M, Zalupski, Mark M
Foilsithe in Invest New Drugs (2016)

Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial

le Sahai, Vaibhav, Catalano, Paul J., Zalupski, Mark M., Lubner, Sam Joseph, Menge, Mark R., Nimeiri, Halla Sayed, Munshi, Hidayatullah G., Benson, Al Bowen, O’Dwyer, Peter J.
Foilsithe in JAMA Oncol (2018)

Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer

le El-Rayes, Bassel F., Zalupski, Mark M., Manza, Stephanie G., Rusin, Barbara, Ferris, Ann Marie, Vaishampayan, Ulka, Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Shields, Anthony F., Philip, Philip A.
Foilsithe 2007

Quality of life in a prospective multi-center phase II trial of neoadjuvant full dose gemcitabine, oxaliplatin and radiation in patients with resectable or borderline resectable pa...

le Serrano, Pablo E., Herman, Joseph M., Griffith, Kent A., Zalupski, Mark M, Kim, Edward J., Bekaii-Saab, Tanios S., Ben-Josef, Edgar, Dawson, Laura A., Ringash, Jolie, Wei, Alice C.
Foilsithe in Int J Radiat Oncol Biol Phys (2014)

Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Canc...

le Tran, Nguyen H., Sahai, Vaibhav, Griffith, Kent A., Nathan, Hari, Kaza, Ravi, Cuneo, Kyle C., Shi, Jiaqi, Kim, Edward, Sonnenday, Christopher J., Cho, Clifford S., Lawrence, Theodore S., Zalupski, Mark M.
Foilsithe in Int J Radiat Oncol Biol Phys (2019)

A phase I/II trial of intensity-modulated radiation (IMRT) dose escalation with concurrent fixed- dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer

le Ben-Josef, Edgar, Schipper, Mathew, Francis, Isaac R, Hadley, Scott, Ten-Haken, Randall, Lawrence, Theodore, Normolle, Daniel, Simeone, Diane M., Sonnenday, Christopher, Abrams, Ross, Leslie, William, Khan, Gazala, Zalupski, Mark M.
Foilsithe 2012

The Quality-of-Life Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

le Herman, Joseph M., Narang, Amol K., Griffith, Kent A., Zalupski, Mark M., Reese, Jennifer B., Gearhart, Susan L., Azad, Nolifer S., Chan, June, Olsen, Leah, Efron, Jonathan E., Lawrence, Theodore S., Ben-Josef, Edgar
Foilsithe 2012

Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

le Kim, Edward J., Sahai, Vaibhav, Abel, Ethan V., Griffith, Kent A., Greenson, Joel K., Takebe, Naoko, Khan, Gazala N., Blau, John L., Craig, Ronald, Balis, Ulysses G., Zalupski, Mark M., Simeone, Diane M.
Foilsithe in Clin Cancer Res (2014)